Zalcman, N.; Gutreiman, M.; Shahar, T.; Weller, M.; Lavon, I.
Androgen Receptor Activation in Glioblastoma Can Be Achieved by Ligand-Independent Signaling through EGFR—A Potential Therapeutic Target. Int. J. Mol. Sci. 2021, 22, 10954.
https://doi.org/10.3390/ijms222010954
AMA Style
Zalcman N, Gutreiman M, Shahar T, Weller M, Lavon I.
Androgen Receptor Activation in Glioblastoma Can Be Achieved by Ligand-Independent Signaling through EGFR—A Potential Therapeutic Target. International Journal of Molecular Sciences. 2021; 22(20):10954.
https://doi.org/10.3390/ijms222010954
Chicago/Turabian Style
Zalcman, Nomi, Mijal Gutreiman, Tal Shahar, Michael Weller, and Iris Lavon.
2021. "Androgen Receptor Activation in Glioblastoma Can Be Achieved by Ligand-Independent Signaling through EGFR—A Potential Therapeutic Target" International Journal of Molecular Sciences 22, no. 20: 10954.
https://doi.org/10.3390/ijms222010954
APA Style
Zalcman, N., Gutreiman, M., Shahar, T., Weller, M., & Lavon, I.
(2021). Androgen Receptor Activation in Glioblastoma Can Be Achieved by Ligand-Independent Signaling through EGFR—A Potential Therapeutic Target. International Journal of Molecular Sciences, 22(20), 10954.
https://doi.org/10.3390/ijms222010954